About the journal
PharmacoEconomics - Open is an open-access journal published by Adis, Springer Healthcare in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 3,190 EUR. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Adis, Springer Healthcare
- ISSN
- 2509-4262 · 2509-4254
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,190 EUR
- Articles in DOAJ
- 0
- Declared review time
- 8 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.springer.com/journal/41669
Index listings
- DOAJ · 2017-10-13
- PUBMED · 2025-12-04
- Indexing
- DOAJ · PUBMED
- APC
- 3,190 EUR
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
0
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
658
Last recorded publication year
2026
h-index
38
i10-index
225
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2017-10-13
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 93%
- ORCID iDs in current deposits
- 88%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Healthcare interventions and outcomesPharmaco-economics - open (Print
- Source type
- journal
- NLM unique ID (PubMed)
- 101700780
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- Pharmaceutical Economics and Policy
- Pharmaceutical Economics and Policy
- Economic and Environmental Valuation
- Economic and Environmental Valuation
Show all subjects (50)
- Multiple Sclerosis Research Studies
- Healthcare Policy and Management
- Multiple Sclerosis Research Studies
- Healthcare Policy and Management
- Medication Adherence and Compliance
- Medication Adherence and Compliance
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Healthcare Systems and Reforms
- Healthcare Systems and Reforms
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- HIV/AIDS Research and Interventions
- Diabetes Treatment and Management
- HIV/AIDS Research and Interventions
- Diabetes Treatment and Management
- Lung Cancer Diagnosis and Treatment
- Rheumatoid Arthritis Research and Therapies
- Antibiotic Use and Resistance
- Lung Cancer Diagnosis and Treatment
- Rheumatoid Arthritis Research and Therapies
- Chronic Disease Management Strategies
- Antibiotic Use and Resistance
- Psoriasis: Treatment and Pathogenesis
- Chronic Disease Management Strategies
- Heart Failure Treatment and Management
- Psoriasis: Treatment and Pathogenesis
- Heart Failure Treatment and Management
- Biosimilars and Bioanalytical Methods
- Healthcare cost, quality, practices
- Vaccine Coverage and Hesitancy
- Vaccine Coverage and Hesitancy
- Inflammatory Bowel Disease
- CAR-T cell therapy research
- Lymphoma Diagnosis and Treatment
- Inflammatory Bowel Disease
- Healthcare cost, quality, practices
- CAR-T cell therapy research
- Lymphoma Diagnosis and Treatment
- Biosimilars and Bioanalytical Methods
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords (DOAJ)
- health outcomes
- health economics
- cost of illness studies
- quality of life studies
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ